Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
84 participants
INTERVENTIONAL
2025-01-26
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This project aims to evaluate the usability and user-friendliness of the Easy-EyeFM platform for physicians. The study will gather feedback from medical professionals to evaluate the intuitiveness and effectiveness of the platform in supporting model customization and medical image analysis tasks.
Subjects will participate in the trial of the Easy-EyeFM platform and the comparison with the existing commercial platform (AutoML) at the appointed time. The researchers will inform subjects of relevant precautions and assist them to read the user manual before the test. Subjects will complete model customization and picture diagnosis within the prescribed test time, and according to the test results, Score the human-computer interaction experience of the AI platform, fill in the questionnaire, and finally complete the evaluation content.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ophthalmic AI-Assisted Medical Decision-Making
NCT06755060
Validation of the Utility of Ophthalmology Intelligent Diagnostic System
NCT03499145
Ophthalmic Multimodal AI-Assisted Medical Decision-Making
NCT06755190
Multimodal Machine Learning for Auxiliary Diagnosis of Eye Diseases
NCT05930444
Real-world of AI in Diagnosing Retinal Diseases
NCT05981950
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group A
EasyEyeFM-AutoML-AI-platform test
AI platforms using
group B
AutoML-EasyEyeFM-AI-platform test
AI-platform using
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EasyEyeFM-AutoML-AI-platform test
AI platforms using
AutoML-EasyEyeFM-AI-platform test
AI-platform using
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have enough time to participate in this program, about 1 hour continuous assessment
* Agree to sign the informed consent form
Exclusion Criteria
* Poor language expression or dialect category is not included in the speech recognition function of the platform
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Hospital of Tsinghua University
OTHER
Beijing Tsinghua Changgeng Hospital
OTHER
Augenarzt-Praxisgemeinschaft Gutblick AG
UNKNOWN
Sankara Nethralaya
OTHER
Department of Medical Services Ministry of Public Health of Thailand
OTHER_GOV
Moorfields Eye Hospital NHS Foundation Trust
OTHER
Pomeranian Hospitals
UNKNOWN
Shanghai Health and Medical Center
UNKNOWN
Hong Kong Eye Hospital
OTHER
Royal Victoria Eye and Ear Hospital
OTHER_GOV
Hanyang University Guri Hospitall
UNKNOWN
Alshifa Trust Eye Hospital
UNKNOWN
Korle-Bu Teaching Hospital, Accra, Ghana
OTHER
Nippon Medical School Tama Nagayama Hospital
UNKNOWN
Tsinghua University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tien Yin Wong
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tien Yin Wong
Role: PRINCIPAL_INVESTIGATOR
Tsinghua University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tsinghua University
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Easy-EyeFM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.